Deuterium Capital Management, LLC Abb Vie Inc. Transaction History

Deuterium Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $43,844 - $52,580	317 Added 19.02%	1,984 $320,000
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $222,251 - $254,908	-1,656 Reduced 49.83%	1,667 $224,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $438,569 - $544,141	3,323 New	3,323 $539,000

3,693

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Deuterium Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Deuterium Capital Management, LLC with notifications on news.